Microbix Biosystems Inc. (TSX:MBX)
Canada · Delayed Price · Currency is CAD 0.3000
-0.0100 (-3.23%)
Sep 18, 2026, 3:02 PM EST
Microbix Biosystems Market Cap
Microbix Biosystems has a market cap or net worth of CAD 41.09 million as of September 18, 2026. Its market cap has increased by 22.50% in one year.
Market Cap
41.09M
Enterprise Value
40.65M
Revenue
15.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.30
ChartMarket Cap Chart
Since October 1, 1992, Microbix Biosystems's market cap has increased from 13.38M to 41.09M, an increase of 207.06%. That is a compound annual growth rate of 3.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 41.09M | 28.54% |
| Dec 31, 2025 | 31.97M | -41.99% |
| Dec 31, 2024 | 55.10M | 3.47% |
| Dec 29, 2023 | 53.25M | -6.55% |
| Dec 30, 2022 | 56.99M | -47.62% |
| Dec 31, 2021 | 108.80M | 135.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NurExone Biologic | 57.84M |
| MedMira | 45.61M |
| BriaCell Therapeutics | 43.32M |
| Sharp Therapeutics | 43.26M |
| Sona Nanotech | 42.98M |
| Sernova Biotherapeutics | 39.65M |
| Defence Therapeutics | 37.89M |
| Medicenna Therapeutics | 36.92M |